[{"Assets_0_Q2_USD":188313000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-69114000.0,"NetIncomeLoss_1_Q2_USD":-43638000.0,"NetIncomeLoss_2_Q2_USD":-87935000.0,"StockholdersEquity_0_Q2_USD":63172000.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]